ArteraAI Breast
Overview
ArteraAI Breast is an AI-powered, digital pathology-based risk stratification tool for patients with early-stage, hormone receptor-positive (HR+), HER2-negative invasive breast cancer. It utilizes multimodal artificial intelligence (MMAI) to analyze digitized histopathology images from breast resection specimens and physician-provided clinical variables (age, tumor size, and nodal status) to generate a personalized risk score. This score estimates a patient’s 5- and 10-year likelihood of developing distant metastasis and stratifies them into low- or high-risk groups. The tool is designed to assist physicians in making prognostic risk-based decisions and to help determine the intensity of treatment, potentially guiding chemotherapy decisions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered risk stratification for early-stage breast cancer
- Utilizes digitized histopathology images and clinical variables
- Provides 5- and 10-year risks of distant metastasis
- Stratifies patients into low- and high-risk groups
- Aids in prognostic risk-based treatment decisions
- Potential to guide chemotherapy benefit decisions
- Fast, convenient, and non-tissue consumptive
- Software-only device
- CE Marked under EU IVDR
- Integrates with existing pathology workflows
Use Cases
- Assessing the likelihood of distant metastasis in HR+/HER2- early-stage breast cancer patients
- Personalizing treatment decisions for breast cancer patients
- Guiding the intensity of adjuvant therapy, including chemotherapy
- Providing prognostic insights to support discussions about prognosis and treatment planning
- Risk stratification at the point of diagnosis
- Integrating AI into pathology workflows for enhanced decision support
Details
| Category | Clinical Decision Support & Reference, Oncology AI, Pathology AI |
| Pricing | Contact for pricing |
| Deployment | Cloud-based (software only) |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Pathology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2026-05-04 | K254115 510(k) | ArteraAI Breast |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ArteraAI Breast
Videos
Product demos, reviews, and walkthroughs for ArteraAI Breast.
No FAQs available yet for this tool.
Investors who backed ArteraAI Breast
Funded through the company that built this tool.





